Ravuconazole (codenamed BMS-207147 and ER-30346) is a potent triazole antifungal, the development of which was discontinued in 2007.

[1] The drug has shown to have a similar spectrum of activity to voriconazole, with an increased half-life.

[2] However, ravuconazole has limited activity against species of Fusarium, Scedosporium, and Zygomycetes.

[3][4] This antiinfective drug article is a stub.

You can help Wikipedia by expanding it.